A GREEN APPROACH FOR THE SYNTHESIS OF DRUG DELIVERY SYSTEM, MESOPOROUS SILICA GRAFTED ACRYLAMIDE â€“Î²- CYCLODEXTRIN COMPOSITE, FOR THE CONTROLLED RELEASE OF CURCUMIN by Mullassery, Manohar D et al.
Vol 11, Issue 9, 2018
Online - 2455-3891 
Print - 0974-2441
A GREEN APPROACH FOR THE SYNTHESIS OF DRUG DELIVERY SYSTEM, MESOPOROUS 
SILICA GRAFTED ACRYLAMIDE –β- CYCLODEXTRIN COMPOSITE, FOR THE CONTROLLED 
RELEASE OF CURCUMIN
MANOHAR D MULLASSERY*, NOELINE B FERNANDEZ, SURYA R, DIANA THOMAS
Department of Chemistry, Fatima Mata National College, Kollam - 691 001, Kerala, India. Email: mdmullassery@gmail.com
Received: 18 April 2018, Revised and Accepted: 02 June 2018
ABSTRACT
Objective: The scope of the present study was the preparation and characterization of a novel composite acrylamide β-cyclodextrin grafted 
3-aminopropyltriethoxysilane bentonite (AMCD-g-APSB), for the controlled delivery of curcumin (CUR).
Methods: AMCD-g-APSB, was synthesized by solvent-free conditions using microwave irradiation. The structure and surface morphology of the 
composite was established using Fourier transform infrared spectroscopy, X-ray diffraction, scanning electron microscopy, thermal analysis, etc.
Results: The swelling percentage of the composite depends on both time and pH of the medium. The maximum swelling of the composite occurred at 
a pH of 7.4. The maximum drug encapsulation was occurring at a pH 3. About 96.5% of drug was loaded at pH 3. In vitro biocompatibility study was 
performed, and the result showed good biocompatibility of the composite in the concentration range 2.5–50 μg/ml.
Conclusions: Drug delivery study of the composite proved that CUR could be successfully released in a controlled manner in the colon without much 
loses of the drug in the stomach.
Keywords: Bentonite, Controlled release, Curcumin, Kinetics.
INTRODUCTION
Cancer is a group of disease involving abnormal cell growth with the 
potential to spread to other parts of the body. Over 100 types of cancer 
affect human. According to WHO, cancer is the second leading cause of 
death globally. Chemotherapy is one of the major treatments of cancer. 
However, chemotherapy has many limitations such as uncontrolled 
drug toxicity, undesirable side effects, etc. Researchers over the last 
two decades concentrated on the investigation studies of anticancerous 
drugs with comparatively low side effects. Curcumin (CUR) is identified 
as one of the natural compounds with significant efficiency and less 
toxic. CUR is a bioactive component of the food additive Curcuma Longa 
which is widely used in Asian countries. The number of cancer patients 
in south Asian countries are relatively low, this may due to the more 
consumption of turmeric as dietaries [1,2].
The bright yellow-orange color of turmeric is due to the fat-soluble 
polyphenolic pigments known as curcuminoids. CUR is the principal 
curcuminoid found in turmeric. The chemical formulae and molecular 
weight of CUR are C21H20O6 and 368.38 g/mol respectively. IUPAC name 
is (1E, 6E)-1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-
3,5-dione. CUR has two aromatic ring systems containing o-methoxy 
phenolic groups, linked with a seven carbon linker consisting of an α, 
β- unsaturated and β-diketone moiety, as shown in Fig. 1. CUR undergoes 
keto-enol tautomerism, in nonpolar and moderately polar solvent, enol 
form of CUR is more stable to exist than the ketoform [2]. Preclinical 
and clinical studies show that CUR exerts anti- inflammatory, anti-
oxidant, anticancerous, neuroprotective, and antidiabetic activities. 
Many studies were reported on the anticancerous activity of CUR 
against colon, liver, pancreatic, ovarian, and breast cancers [3,4].
CUR has some important drawbacks such as its low water solubility, 
rapid hydrolysis under high alkaline conditions, and susceptibility to 
photochemical degradation. It also exhibits poor absorption, rapid 
metabolism, and low bioavailability. These limitations can be overcome 
by the use of a biocompatible and novel drug carrier system for the 
effective encapsulation and successive release of CUR to the targeted 
site without losing its anticancerous activity [5].
The mesoporous silica materials can be used as a potential drug carrier 
system for the controlled and targeted drug delivery. Hence, many 
studies have been reported in porous silica-based materials as drug 
carriers [6-8]. Table 1 shows different kinds of modified mesoporous 
systems used as drug delivery systems. Mesoporous materials have 
tunable pore size; it can change its pore size from 2 to 50 nm. Hence, 
this material can be used as a better drug carrier system for different 
kinds of bioactive materials of with variable size [9].
Montmorillonite belongs to the smectite group, composed of silica 
tetrahedral sheets layered between alumina octahedral sheets at the 
ratio of 2:1, respectively. The mineral composition of bentonite is quite 
variable depending on its origin. In general, sodium montmorillonite 
represents the main components in these clays (up to 80% by weight). 
However, for the development of bentonite-based controlled release 
formulations, their properties must be needed to modify for improving 
their affinity for bioactive drug molecules. Intercalation of polymer 
matrix onto clay scaffold is one of the treatment techniques is gaining 
attention, as the composite hydrogel has got the combined advantages 
of biodegradability of polymer matrix and tunable pore size of the 
mesoporous silica.
In the present study, a biocompatible pH-sensitive composite was 
prepared by the grafted copolymerization of β-cyclodextrin - acrylamide 
(AMCD) intercalated by the modified 3-Aminopropyltriethoxysilane 
bentonite (APSB) for the controlled release of CUR [16]. During the 
intercalation, a calculated amount of ethylene glycol dimethacrylate 
(EGDMA) was used a crosslinker agent because it can form stable 
networks by withstanding wide range of pH and temperature [17]. 
© 2018 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2018.v11i9.26769
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The intercalated composite of the natural clay (bentonite) with the 
polysaccharides could retain its properties such as biodegradability, 
non-toxicity, swelling, behavior, etc. [18]. The grafted composite of clays 
with the hydrogel can act as a potential drug delivery system [19,20].
MATERIALS AND METHODS
Materials
The bentonite clay was procured from Ashapura Clay Mines (Gujarat, 
India). β-cyclodextrin (CD), EGDMA, CUR were purchased from Tokyo 
Chemical Industry (Japan). AM was received from Merck Life Science Pvt. 
Ltd (India). Ceric ammonium nitrate (CAN) was obtained from Merck 
Specialities Pvt. Ltd (India). Acetone and α, α-azobisisobutyronitrile 
(AIBN) and 3-aminopropyl triethoxysilane were procured from 
Spectrochem Pvt., Ltd (India). Dulbecco’s Modified Eagle’s Medium 
(DMEM), 3-(4, 5-dimethylthiazol-2-yl)-2, and 5-diphenyltetrazolium 
bromide (MTT) were purchased from Himedia (Mumbai, India). 
U87MG glioma cell line was provided by NCCS (Pune, India). The pH of 
the medium was adjusted using phosphate and citrate buffer. Distilled 
water with specific conductivity <1 μS/cm was used throughout the 
study. The stock solution of CUR was prepared in ethanol. CUR solution 
was freshly prepared for each and every day use.
Synthesis of the drug delivery system (AMCD-g-APSB) involves the 
following steps
Preparation of APSB
About 10 g of powdered bentonite was dispersed in excess of 1 M 
NaCl solution and kept for 24 h. The solution was centrifuged and 
washed with distilled water till it was completely free from chloride 
ions. After the removal of chloride ions, the clay was dried at 80°C 
and grained to powder. About 5.0 g of Na-B was dried at 60°C for 24 h 
and dispersed in 100 ml of methanol. Separately, a solution with 5 g 
of 3-aminopropyltriethoxysilane (pur) was dissolved in 100 ml solvent. 
This solution was added to the dispersion containing Na-Bentonite [21]. 
The dispersion was stirred at 50°C under magnetic stirring for 72 h. 
After complete stirring, the product was centrifuged and washed with 
distilled water, dried at 80°C and grained to fine powder.
Solvent-free synthesis of AMCD
The grafted copolymer derived from AAm (pure) and β-CD (pure) was 
prepared by microwave assisted, free radical-induced polymerization 
method. About, 1.0 g β-CD was dispersed in 120 ml of water and 5 g of 
AM was mixed with 30 ml of water and added to β-CD-water mixture 
and stirred for 1 h. 300 mg of CAN (pure) was dissolved in 30 ml of 
water and added to the above dispersion [22-25]. The dispersion was 
irradiated by microwave for 2 min. It was left for overnight and then 
precipitated using acetone (pure). The unreacted monomer and other 
reagents were removed by washing with aqueous ethanol (30%, v/v). 
The grafted polymer was then dried at 40°C to a constant weight and 
converted to fines.
Preparation of AMCD-grafted-APSB
The preparation of AMCD-g-APSB was represented in Scheme 1. About 
5.0 g of APSB, 2.5 g of AMCD, 0.50 g of EGDMA and 0.04 g of AIBN were 
added to a three neck RB flask which was equipped with a magnetic 
stirrer and a reflux condenser. To the above mixture, 25 ml of methanol 
was added, and the flask was purged by dry O2 free N2 for 30 min. The 
mixture was heated at 70°C for 5 h and stirred continuously (1250 rpm). 
The product obtained was separated by filtration and washed well with 
distilled water and methanol (30%, v/v) to remove the by-products. 
The product was dried at 60°C and kept overnight and ground to an 
average particle size of 0.095 mm.
Characterization
The Fourier transform infrared spectroscopy (FTIR) spectral analysis 
was performed in transmission mode using a Bruker spectrophotometer 
(Germany). Spectral scanning was done at 4 cm−1 resolutions with 32 
scans over spectral range from 400 and 400 cm−1. XRD studies were 
used to find out the crystallinity of a substance. X-ray diffraction (XRD) 
measurements were carried out on a Rigaku Geigerflex XRD meter with 
Fig. 1: Structure of curcumin
Table 1: List of different kinds of modified mesoporous silica materials as drug delivery system
Drug delivery system Drug Reference
Montmorillonite-poly lactic-coglycidic acid composite Insulin [10]
Amino functionalized mesoporous nanomaterial 5-Flurouracil [11]
Alginate encapsulated mesoporous silica Indomethacin [12]
Amine functionalized cubic mesoporous silica material CUR [13]
3-aminopropyltriethoxysilane modified mesoporous silica material CUR [14]
Chitosan mesoporous silica material CUR [2]
Carboxymethyl cellulose grafted mesoporous silica material CUR [15]
Present study CUR
CUR: Curcumin
Scheme 1: Preparation of acrylamide β-cyclodextrin grafted 
3-aminopropyltriethoxysilane bentonite
374
Asian J Pharm Clin Res, Vol 11, Issue 9, 2018, 372-380
 Mullassery et al. 
Ni filtered Cu Kα radiation at 40 kV, 20 mA. The thermal analyses were 
made on a Mettler Toledo Star system under nitrogen atmosphere with 
a heating rate of 20°C min−1. A Philips model XL 30 CP scanning electron 
microscope (SEM) was used to take micrographs. In this instrument, 
cryofreezing method was used for taking SEM photographs at 15 kV 
and 20 kV with a working distance of 6 mm, in which freezed samples 
were coated with a thin layer of gold to make the surface conductive 
toward electron beam. The pH of the medium was measured using a pH 
meter (Systronic model μ 362, India). Absorbance of CUR in the drug 
carrier was conducted by UV-Visible spectrophotometer (Systronics, 
India) at λmax of 428 nm.
Swelling studies
Swelling of drug carrier systems was important in the effective and 
targeted delivery of drugs. The swelling behavior of the sample 
was studied as a function of pH (2 to 9). The pH of the solution was 
adjusted by varying concentrations of NaOH and HCl. The samples were 
immersed in excess aqueous medium of desired pH for 10 h to achieve 
the equilibrium. The swollen samples were then separated and excess 
surface adhered water molecules were removed by blotting. It was 
then dried in an air oven at 50°C until there was no change in the dried 
mass of the sample. The percentage equilibrium water uptake can be 
calculated as (Equation 1).





Stability study of CUR at different pH conditions
The stability study of CUR was carried out at different pH conditions of 
2, 4, 6, 7, and 8. A stock solution of CUR was prepared by dissolving about 
5 mg of CUR in 100 ml of methanol-distilled water mixture (60:40 v/v). 
Each experiment was carried out in dark conditions, incubated at 37 
± 1°C in citrate buffer and phosphate buffer. At definite time intervals, 
5 ml of the solution was pipetted out, filtered, and measured for the 
concentration using the UV-visible spectrophotometer (Systronics, 
India) at λmax of 428 nm.
Drug encapsulation efficiency studies
About 0.1 g of the composite and CUR solution at an initial 
concentration of 50 mg/l were taken in amber-colored stoppered 
bottle and stirred at 1000 rpm for 6 h. To get the maximum 
encapsulation, the analysis was carried out at different pH range 
of 2–7. The encapsulation study was also repeated for another CUR 
concentration of 75 mg/l. Along with the encapsulation efficiency 
study of CUR onto the drug delivery composite AMCD-g-APSB, a 
comparative study was also done with APSB, a precursor unit of 
the composite. The percentage of drug encapsulation efficiency was 




Total Curcumin Free Curcumin 100%
Total Curcumin
DEE  (2)
In vitro drug release study
Release study of CUR from AMCD-g-APSB and APSB were investigated 
on different pH conditions of 2.4 ± 0.2, 6 ± 0.2, and 7.4 ± 0.2. About 0.1 g 
of CUR-loaded AMCD-g-APSB was put in different pH of 2.4, 6, and pH 7.4 
separately placed on the water bath shaker of constant temperature 
of 37 ± 1°C rotated at 100 rpm. At the specified intervals, about 5 ml 
of the solution was pipetted out and filtered. The concentration of 
drug release was measured spectrophotometrically. The release 
studies were performed thrice and the mean percentage was taken as 
± standard deviation (SD). The cumulative release profile of CUR was 









e release  (3)
The in vitro release kinetics studies were analyzed using the Peppas 






where Mt is the amount of drug released at time t and is the amount of 
the drug release completely. k is the rate constant and n is the diffusion 
exponential.
Cell viability analysis and cell culture conditions
U87MG glioma cells were used as an in vitro model for toxicological 
studies. The U87MG cells were cultured in DMEM under the temperature 
of 37°C and supplemented with 10% FBS in an atmosphere of 5% CO2 
and a humid atmosphere was maintained. The cells were trypsinized 
with buffered saline solution containing 0.25% of trypsin and 0.03% 
of EDTA. The cells were placed to a culture plate for 24 h. MTT assay 
is a colorimetric assay used for the determination of cell proliferation 
and cytotoxicity, based on the reduction of the yellow-colored water-
soluble tetrazolium dye MTT to formazan crystals. Mitochondrial 
lactate dehydrogenase produced by live cells reduces MTT to insoluble 
formazan crystals, which on dissolution into an appropriate solvent 
exhibits purple color, the intensity of which is proportional to the 
number of viable cells and can be measured spectrophotometrically at 
570 nm. Briefly, seeded using a 200 μl cell suspension in a 96-well plate 
at a cell density of 20,000 cells per well without the test agent. Allow 
the cells to grow for about 12 h. Add appropriate concentrations of the 
test agent (2.5 μg/ml, 5 μg/ml, 10 μg/ml, 20 μg/ml, and 40 μg/ml). 
Incubate the plate for 24 h at 37°C in a 5% CO2 atmosphere. After 
the incubation period, plates are taken from the incubator, and spent 
media is removed and MTT reagent is added to a final concentration of 
0.5 mg/ml of total volume. Wrap the plate with aluminum foil to avoid 
exposure to light. Return the plates to the incubator and incubate for 
3 h. The MTT reagent is removed and then add 100 μl of solubilization 
solution (DMSO). The absorbance is measured on a spectrophotometer 
at 570 nm and 630 nm is used as a reference wavelength. The cell 
viability percentage and percentage of cytotoxicity can be calculated by 
the following equations




lity % ×=  (5)
=Cytotoxicity %  100 –  cell viability %  (6)
Statistical analysis
All the results were expressed as mean±SD. Statistical analysis was 
performed with origin 8.0 (Origin –Lab Corporation, USA).
RESULTS AND DISCUSSION
Synthesis of the composite and characterization
Sodium bentonite (NB) was the starting material used in the synthesis 
of the drug delivery system AMCD-g-APSB. AMCD-g-APSB was formed 
by the grafting copolymerization of the biocompatible monomer units 
AMCD and APSB. The grafting synthesis was carried out in the presence 
of the cross-linking agent EGDMA and the free radical initiator AIBN. 
The surface of NB was modified by exchanging water molecules with 
APS in ethanol medium [26]. The water molecules present in the ethanol 
medium catalyzed the surface silylation of Na-B by APS. Because of the 
intercalation of the APS, the basal spacing of APSB was increased [27]. 
The copolymer hydrogel, AMCD can act as a “gate keeper” molecule in 
which it can be introduced to the tuning pore size of the clay for the 
effective loading and the controlled release of drug [28-30]. During 
the synthesis of AMCD from β-CD and AAm, CAN was used as the free 
radical initiator.
The FTIR spectra of NB, APSB, AMCD, AMCD-g-APSB, CUR, and CUR-L-
AMCD-g-APSB were shown in Fig. 2. A broad absorption band observed 
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at 3615 cm−1 of Na-B represents stretching vibrations of different –OH 
groups present in Mg-OH-Al, Al-OH-Al and Fe-OH-Al. A strong peak at 
1048 cm−1 showed the O-Si-O bending vibration. The peaks at 545 cm−1 
and 460 cm−1 represent the bending vibrations of Al-O-Si and Si-O-Si 
respectively. Another peak at 950 cm−1 corresponds to Al-O-Al bending 
vibration. The H-O-H bending vibration of water molecules intercalated 
in the clay mineral was represented by a peak at around 1628 cm−1. In 
APSB, two bands were observed nearly at 1552 and 1493 cm−1 which 
can be explained due to the bending vibrations of N-H and CH2 group, 
respectively. Another band at 3010 cm−1 due to the C-N stretching and 
the bands at 2860-2924 cm−1 represent the C-H vibrations of amino 
propyl group. The presence of two bands due to –NH and –CH in the 
spectrum could be considered as an evidence for the intercalation of 
silane molecules in the clay mineral. After silylation, it can be seen that 
silane group is present both as covalently bonded to the clay mineral 
and by hydrogen bonding interaction with intercalated water molecules 
as evident from the broad band observed in the spectrum of ASPB 
between 3010-2700 cm−1.
In the FTIR spectrum of AMCD, a characteristic band of ether linkage 
was found at 1030-1032 cm−1. The band at 1628 cm−1 may be due to 
the O-H bending vibrations. Two prominent bands of Am at 1651 and 
1602 cm−1 were due to the presence of C-O stretching and N-H bending 
vibrations of amide group, respectively. An overlap band of N-H and 
O-H stretching peak were observed at 3188–3499 cm−1. A shoulder at 
around 1450 cm−1 (C-N str) and a prominent peak at 1022 cm−1 were 
observed which resulted from the CH-O- CH2 group which occurred 
during grafting reaction.
In the FTIR of AMCD-g-APSB, a peak of -CH-O-CH2 was shifted to lower 
intensity. A new peak at 1205 cm−1 observed can be attributed to the 
C-O-O- stretching vibrations of ester linkage formed between COOH 
group in the AMCD and the hydroxyl groups of APSB. In the FTIR 
spectrum of CUR a broad absorption band at 3520 cm−1 was due to 
phenolic OH group. The aromatic ring of CUR gave two peaks at 1504 
and 1435 cm−1 resulted from CH bending and CH stretching vibrations, 
respectively. Most of the peaks in CUR were retained after loading with 
DDS showing the effective encapsulation of drug onto composite by 
weak physical adsorption.
Fig. 3 represents the XRD patterns of NB, APSB, AMCD, AMCD-g-APSB, 
Cur-L-AMCD-and g-APSB. NB showed a peak at 2θ = 6.89 of basal 
spacing 13.02 Å. After silylation, the basal spacing was increased 
to d001= 21.15 Å which resulted in the lowering of 2θ value to 4.17. 
In APSB, a new peak was appeared [19] which correspond to d002 
reflection. Compared to the XRD spectrum of NB the increase in basal 
spacing of APSB by 8.13 Å is an evidence for the successive intercalation 
of 3-aminopropyltriethoxysilane moiety. The broad peaks in the XRD 
of AMCD indicate the amorphous behavior of the polymer formed. 
Successful grafting led to an increase in amorphous nature and the 
swelling features. In the XRD of AMCD-g-APSB, the peaks of APSB were 
retained and a broad peak indicated the successful grafting of AMCD on 
APSB. The XRD pattern of the composite and the drug-loaded composite 
had no remarkable changes as evident from the Figure.
The TG and DTG curves of NB, APSB, AMCD, AMCD-g-APSB, and 
CUR-L-AMCD-g-APSB were shown in Fig. 4. For NB dehydration at 
temperature below 100°C was initially observed, which may be due to 
the elimination of weakly adsorbed water molecules on the edges and 
in the interlayer space. Similar behavior was also shown by APSB which 
showed weight loss up to 100°C. The weight loss of APSB was higher 
than that of NB possibly due to the presence of intercalated silane 
molecules. Three distinct mass loss events were observed in the DTG 
curve of APSB between 240°C and 640°C. These correspond to the loss 
of silane molecules that were weakly adsorbed by hydrogen bonding, 
intercalated and chemically bonded to the clay mineral, respectively. 
The observed initial mass loss at around 80°C for AMCD was explained 
for the presence of moisture, solvents, and unreacted monomers. 
However, no mass loss occurred at the later stage up to 250°C. The 
weight loss at 275°C, 375°C, and 575°C correspond to breaking of rigid 
polymer network. Compared to AMCD, the composite AMCD-g-APSB 
was thermally more stable and showed no weight loss after 430°C. 
Fig. 2: Fourier transform infrared spectroscopy of (a) Sodium 
bentonite (b) 3-aminopropyltriethoxysilane bentonite (APSB) 
(c) acrylamide β-cyclodextrin (AMCD) (d) AMCD-grafted-APSB 







Fig. 3: X-ray diffraction of (a) acrylamide β-cyclodextrin (AMCD) 
(b) sodium bentonite (c) 3-aminopropyltriethoxysilane bentonite 
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It showed four distinct weight loss events. The initial loss in weight 
below 100°C may be due to the loss of moisture from the composite. 
According to the literature, the weight loss observed for AMCD-g-APSB 
between 300 and 400°C can be attributed to the loss of intercalated APS 
molecules in the interlayer of NB. The TG and DTG curves of drug loaded 
composite showed three mass loss events. The initial weight loss was 
due to loss of moisture followed by two mass loss events which was due 
to the rupture of CUR moiety which was loaded onto DDS.
The SEM images of APSB, AMCD, AMCD-g-APSB, and CUR-loaded AMCD-
g-APSB were shown in Fig. 5. The NB has corn flake-like crystals with 
fluffy appearance revealing its extremely fine platy structure (figure 
not shown). Compared with the morphology of NB, the image of APSB 
appeared as individual clubbed particle. The surface of AMCD appeared 
rough with porous nature. These regular pores were connected to each 
other to form capillary channels. In general, the inorganic particles with 
polar lamellae and the hydrophobic units (3-aminopropyl triethoxy 
part in the silylating agent) undergo aggregation [17]. The surface of 
AMCD-g-APSB appeared to be irregular due to the presence of larger 
number of pore cavities. The surface of CUR-loaded AMCD-g-APSB seen 
to be as regular and homogeneous, due to the loading of CUR in the 
pore cavities.
The swelling profile of the composite at different pH and at different 
time intervals were shown in Fig. 6. The swelling percentage of the 
composite strongly depends on both time and pH of the medium. For 
acidic pH, the swelling percentage was lower than that in alkaline pH 
condition. The minimum swelling index was at pH 2, and maximum was 
at pH 7.4. The swelling of the composite increases with pH and attains 
a maximum at pH 7.4 and then gradually decreases. In high-pH medium 
(7.4), the hydrophilic groups(-OH) on the composite were getting 
ionised and the electrostatic repulsion between these negative charges 
led to the high swelling of the composite; however, in acidic medium, 
the absence of swelling caused the collapse of AMCD-g-APTSB. Similar 
results were reported by Anirudhan and Sandeep [31].
The swelling process was found to be very fast and reached a maximum 
at 60 min after that it was slowly increased. The initial burst in swelling 
of the composite may due to the presence of the hydrophilic group 
on the surface of AMCD-g-APSB. After 60 min, the decrease in rate of 
swelling can be attributed to the entering of water molecules in the 
internal boundary of the clay molecules which is initially not exposed 
to water molecules. Similar swelling pH dependencies were reported in 
the case of other composite hydrogels [32].
The physical and the chemical stability of CUR deeply depend on the 
pH [33] and light [21]. CUR undergoes photochemical degradation; 
Fig. 4: Thermogravimetry-differential thermal analysis of (a) Sodium bentonite (b) 3-aminopropyltriethoxysilane bentonite (APSB) (c) 





Fig. 5: Scanning electron microscope images of (a) grafted 
3-aminopropyltriethoxysilane bentonite (APSB) (b) acrylamide 
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therefore, all studies are carried out in amber-colored bottle. CUR was 
unstable at alkaline pH conditions. About 90% of CUR was degraded 
at the pH of 7.4 with in initial 15 min. At the same time, the stability of 
CUR at acidic pH was very high, only 3.4% of the drug was degraded 
within 6 h. The half-life period of CUR on the pH 3, 5, 6, 7, and 8 are 
118.63, 199.08, 195.69, 9.40, 1.05 and 14.04 min respectively. The 
high stability of CUR at acidic conditions may due to the presence of 
conjugated diene moiety. On increasing the pH (alkaline conditions), 
the –OH group at phenol gets easily deprotonated which causes the 
degradation [34]. The result of the present analysis on the stability 
study of CUR was compared with previous results and was found to be 
in good agreement [35].
The various formulation parameters in the synthesis of the composite 
were given in Table 2. The percentage of encapsulation was increased 
with increase in amount of AMCD. After attaining an optimum value 
of 2.5 g, the encapsulation efficiency and the swelling percentage 
is decreased. This can be explained by the fact that with increasing 
the amount of AMCD, the diffusion of the drug molecules into the 
internal pore cavities of the clay gets decreased. The encapsulation 
efficiency also depends on the cross-linking agent. The optimum 
amount of cross-linking agent is found to be 0.5 g. On increasing 
the amount of cross linker over the optimum value of 0.5 g, the 
encapsulation capacity of the composite is getting decreased. This 
may due to compound formation of EGDMA itself with the composite 
and the composite becomes more rigid and the pore volume gets 
decreased [36].
The encapsulation study of CUR onto the composite AMCD-g-APSB 
was carried out at different pH conditions from 2 to 7. For comparison, 
the drug encapsulation study of the monomer unit of the composite 
(APSB) was also carried out. In the case of composite, the drug 
encapsulation was occurring maximum (96.5%) at a pH of 3. Whereas, 
the encapsulation of drug onto APSB at the same pH of 3 was only 81%. 
The encapsulation study of AMCD-g-APSB and APSB at different pH 
conditions were represented in Fig. 7. In the case of APSB, there was a 
weak interaction between the –NH2 group present in the functionalized 
bentonite and the phenolic –OH group present in the CUR. With increase 
in the –NH2 functionalization on the clay surface, the encapsulation 
efficiency increases. The higher efficiency of AMCD-g-APSB compared 
to APSB is due to the weak interaction of CUR molecules with cone 
such as cavities of β-CD apart from interlayer cavities of clay. Moreover, 
the AMCD is behaving as a gate keeper which may regulate the entering 
and release of the drug molecules in the composite. The encapsulation 
efficiency of the composite depends on the amount of the monomers, 
cross-linking agent and also the pH of the medium. Acrylamido-2-
methylpropane sulfonic acid grafted N-maleoylchitosan intercalated 
montmorillonite showed encapsulation efficiency of 94% [31] whereas 
alginate/chitosan-coated mesoporous silica-based nanocarriers 
showed a value of 85.7% [36]. The AMCD-g-APSB (present study) 
showed higher encapsulation efficiency of 96.1% compared with 
other mesoporous silica materials. Therefore, it can be concluded that 
the prepared composite hydrogel is effective for the controlled and 
targeted delivery of therapeutics.
In-vitro release analysis
The controlled release study was carried out at different pH of 2.4, 
6, and 7.4 at the body temperature condition of 37°C was shown in 
Fig. 8. The maximum release of drug was seen at pH 6. About 78.5% 
of drug was released within 48 h at pH 6.0. About 20% of the drug was 
released slowly within initial 10 h. After that, there was a controlled 
release of the drug. At the pH of 2.4, release of drug was comparably 
less, about 25.6% of drug was released within 48 h. Similarly, the 
release percentage (38.1%) of drug at pH 7.4 was also relatively small. 
The release of drug is related with the swelling index of the polymer. 
The maximum swelling of the polymer among three different pH are 
7.4>6>2.4. However, the release of drug is in the following order of 
6>7.4>2.4. This may due to the fact that the CUR is unstable at pH 7.4.
The release study was also done for the monomer unit APSB, under the 
same procedure as carried out for AMCD-g-APSB. For APSB, the drug 
release was maximum at the pH 6 (41.2%) and also shows a minimum 
Table 2: Formulation parameters used in the synthesis of AMCD-g-APSB composite
Sample code APSB/g AMCD/g Cross linking agent/g Swelling % of the composite (g/g) Encapsulation efficiency (%)
A1 5 0.5 0.5 92±1.0 49±028
A2 5 1.0 0.5 109±0.5 52±0.86
A3 5 1.5 0.5 124±1.5 60±0.57
A4 5 2.0 0.5 1311.3 63±0.28
A5 5 2.5 0.5 200±1.3 96.1±2.0
A6 5 5.0 0.5 86±0.57 45±2.1
A7 5 2.5 1.0 99±1.0 50.5±1.7
A8 5 2.5 0.75 119±0.76 56±3.0
A9 5 2.5 0.5 200±1.3 96.1±2.0
A10 5 2.5 0.25 162±1.9 81±2.0
All the results are expressed as±SD. SD: Standard deviation, AMCD-g-APSB: β-cyclodextrin grafted 3-aminopropyltriethoxysilane bentonite
Fig. 7: Percentage of encapsulation efficiency of the acrylamide 
β-cyclodextrin-g-grafted 3-aminopropyltriethoxysilane bentonite 
(APSB) and APSB as a function of pH (triplicates for each sample 
were analyzed and each datum point represents the mean 
value±standard deviation; n=3)
Fig. 6: Swelling study of the composite acrylamide β-cyclodextrin-
g-grafted 3-aminopropyltriethoxysilane bentonite at different 
time intervals and at different pH (triplicates for each sample 
were analyzed and each datum point represents the mean 
value±standard deviation; n=3)
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at pH 2.4 (18.5%) and for pH 7.4 (28.6%). APSB is a good DDS and its 
efficiency can be improved by grafting process.
The pH of tumour cells is lower than the normal cells. The pH of tumor 
cells ranges from 5.0 to 6.0. In the present study, the maximum release 
of CUR is occurring at acidic pH of 6.0, so the developed biodegradable 
composite is better for the controlled release of CUR to the tumor cells.
The in-vitro drug release study was analyzed using Peppas kinetic 
equation (Fig. 8). In Peppas equation the value of k gives an idea about 
the interaction of drug onto the DDS. Smaller the value of k, weaker is 
the interaction between the drug and the DDS. The value of n determines 
the release mechanism. The fitting of Peppas’s kinetic model was 
analyzed on both AMCD-g-APSB and APSB at pH 6. The value of n=0.778 
for AMCD-g-APSB showed that the release of drug follows non-Fickian 
mechanism. The release of drug depends both on the diffusion of drug 
and the swelling of the composite. The value of k for AMCD-g-APSB and 
APSB are 0.0314 and 0.0743, smaller the value of k indicates the weaker 
interaction between the drug and the DDS [37].
Cell viability analysis
The cell viability was analyzed by MTT method using U87MG cell line 
incubated to 48 h under variable concentration of 2.5–40.0 µg/ml as 
shown in Figs. 9 and 10. The cell viability of above 80% was considered 
as cytocompatible and nontoxic [38]. The percentage cell viability of the 
DDS (AMCD-g-APSB) was not below 80% even at higher concentration 
of 40.0 µg/ml. The percentage cell viability decreases with increase in 
the concentration of DDS. In the case of the drug-loaded composite, the 
percentage of cell viability was decreased from 74% to 50.6% when the 
concentration of drug was increased from 5 µg/ml to 10 µg/ml. This 
showed that the percentage of the cell toxicity was increased by the 
factor 22.4%, when the concentration was doubled [39].
CONCLUSION
In the present work, we synthesized a novel drug delivery system by a 
green synthetic approach. The composite was characterized by FTIR, 
Fig. 8: In vitro release of curcumin from AMCD-grafted 3-aminopropyltriethoxysilane bentonite (APSB) and APSB and the corresponding 
Peppas kinetic model (triplicates for each sample were analyzed and each datum point represents the mean value±standard 
deviation; n=3)
Fig. 9: In vitro cell viability of (a), the composite acrylamide 
β-cyclodextrin-g-grafted 3-aminopropyltriethoxysilane bentonite 
(b) curcumin (CUR)-L-composite, and (c) CUR (triplicates for each 
sample were analyzed and each datum point represents the mean 
value±standard deviation; n=3)
Fig. 10: The images of morphological changes in cells during the 
cell viability assay. (a) Controlled; (b) acrylamide β-cyclodextrin-
grafted 3-aminopropyltriethoxysilane bentonite (AMCD-g-APSB 
(c) Curcumin (CUR) and (d) CUR-L-AMCD-g-APSB at 5 µg/ml 
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XRD, SEM, and differential scanning calorimetry. The swelling behavior 
of the composite was depending on the pH, time, and composition of 
the components. The encapsulation efficiency was pH dependent. 
For a comparative study, the in vitro release study of APSB, one of the 
monomer units of this composite was also carried out. The maximum 
release of CUR was occurring at a pH 6. The CUR release from AMCD-g-
APSB followed non-Fickian mechanism. The release of drug depends on 
both the diffusion and the swelling of the composite. The in vitro MTT 
assay on U87MG cell line confirmed the biocompatibility of the drug 
delivery system. The DDS was more potent for the controlled release of 
CUR to the tumor cells.
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